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Sox2, which encodes an SRY-like HMG box transcription factor, is critical for vertebrate development. Sox2 mediates its transcriptional effects
through the formation of complexes with specific co-factors, many of which are unknown. In this report, we identify Oct-1, encoded by the
Pou2f1 gene, as a co-factor for Sox2 in the context of mouse lens and nasal placode induction. Oct-1, Sox2, and Pax6 are co-expressed
during lens and nasal placode induction and during subsequent developmental stages. Genetic combination of Sox2 and Pou2f1 mutant alleles
results in impaired induction of the lens placode, an ocular phenotype that includes anophthalmia, and a complete failure of nasal placode
induction. These ocular and nasal phenotypes closely resemble those observed in Pax6 null embryos. Moreover, we identify DNA-binding sites
that support the cooperative formation of a complex between Sox2 and Oct-1 and mediate Sox2/Oct-1-dependent transactivation of the Pax6 lens
ectoderm enhancer in vitro. We demonstrate that the same Sox- and Octamer-binding sites are essential for Pax6 enhancer activity in the lens
placode and its derivatives in transgenic mouse embryos. Collectively, these results indicate that Pou2f1, Sox2 and Pax6 are interdependent
components of a molecular pathway utilized in both lens and nasal placode induction.
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Vertebrate sensory structures, including the lens, ear and
nose, develop through multi-step inductive processes that
involve the formation of a neural plate stage pre-placodal
region (PPR) and the subsequent formation of discrete
ectodermal thickenings called placodes (reviewed in Streit,
2004; Bhattacharyya and Bronner-Fraser, 2004; Brugmann and
Moody, 2005; Schlosser, 2006). Induction of the PPR in chick
and Xenopus is dependent upon Fgf signaling and attenuation
of Wnt and Bmp signaling (Litsiou et al., 2005; Ahrens and
Schlosser, 2005). Similarly, Fgf signals are required for the
induction of the individual sensory placodes (Faber et al., 2001;
Phillips et al., 2004; Martin and Groves, 2005; Ladher et al.,
2005; Bailey et al., 2006), while Wnt signaling is required for
appropriate placode placement (Smith et al., 2005; Ohyama et⁎ Corresponding author. Fax: +1 617 525 4751.
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doi:10.1016/j.ydbio.2006.10.047al., 2006). In contrast to PPR induction, Bmp signals play a
positive role in the induction of the mouse lens placode (Furuta
and Hogan, 1998; Wawersik et al., 1999). Several transcription
factor families including Six, Eya, Pax, Pitx, Msx and Sox are
expressed in and important for the formation of all placodes
(reviewed in Streit, 2004; Bhattacharyya and Bronner-Fraser,
2004; Brugmann and Moody, 2005; Schlosser, 2006). Thus,
while many molecules critical for sensory placode induction
have been identified, detailed molecular mechanisms that
control different stages of placode induction, particularly in
mammals, are still not fully understood.
Sox2, a Group B1 SRY-related HMG box containing trans-
cription factor, has emerged as an important factor in vertebrate
sensory development (Dong et al., 2002; Fantes et al., 2003;
Kiernan et al., 2005; Ragge et al., 2005; Hagstrom et al.,
2005; Taranova et al., 2006). While Sox2 is not expressed in
the early PPR (Wood and Episkopou, 1999), it is expressed in
the distinct lens, nasal, and otic placodes (Kamachi et al.,
1998; Wood and Episkopou, 1999). Disruption of Sox2
expression in the mouse otocyst disrupts formation of the ear
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ment (Kiernan et al., 2005). In the chick lens, Sox2 cooperates
with Pax6 to regulate crystallin gene expression (Kamachi et
al., 2001), and mutation of SOX2 in humans results in severe
eye phenotypes ranging from microphthalmia to anophthalmia
(Fantes et al., 2003; Ragge et al., 2005; Zenteno et al., 2005;
Hagstrom et al., 2005).
As with other Sox family members, Sox2 requires co-factors
to mediate transcriptional control over its targets (reviewed in
Kamachi et al., 2000). Two Sox2 co-factor families have been
identified, the paired-type homeodomain containing family
(Pax), and members of the POU family (Ambrosetti et al., 1997;
Botquin et al., 1998; Nishimoto et al., 1999; Ma et al., 2000;
Kamachi et al., 2001; Di Rocco et al., 2001; Aota et al., 2003;
Tanaka et al., 2004; Rodda et al., 2005; Okumura-Nakanishi et
al., 2005). In the context of placode formation, however, the co-
factors that interact with Sox2 are unknown.
Here, we identify Oct-1 as a Sox2 co-factor in the context of
murine lens and nasal placode induction. We demonstrate that
Oct-1, Sox2 and Pax6 are co-expressed in cells of the nasal and
lens placodes, and that compound mutations in Pou2f1 and
Sox2 disrupt lens and nasal morphogenesis while isolated
mutation of Pou2f1 or Sox2 does not. We provide in vitro
biochemical evidence that Sox2 and Oct-1 synergistically
activate expression of Pax6 by cooperatively binding to the
Pax6 lens ectoderm enhancer (EE). Furthermore, we show
that the same Sox and Octamer DNA-binding sites are required
for Pax6 lens enhancer activity during embryogenesis in
transgenic mouse models. Thus, compromised Pax6 expression
likely accounts for the failure of lens and nasal placode
induction in Oct-1−/−, Sox2+/− embryos. These data are
consistent with common molecular mechanisms controlling
Pax6 expression during lens and nasal placode induction.
Materials and methods
Cell culture and RT-PCR
The rabbit lens epithelial cell lines B3, LEP2, and N/N1003Awere cultured in
DMEM supplemented with 10% rabbit serum and penicillin/streptomycin. Cells
were harvested and total RNA isolated utilizing Qiagen RNeasy® Kits according to
themanufacturer's instructions. RNA fromE13.5 eyes was screened forPou2 genes
using the degenerate primers POU2FF 5′-AGTTYGCYMRSACYTTCAARCA
and POU2FR 5′-GTCRTTKCCATABARYTTBCCC. Specific primers for Sox2
(SOX2LRT 5′-CACAACTCGGAGATCAGCAA and SOX2RRT 5′-
CTCCGGGAAGCGTGTACTTA); Pax6 (PAX6LRT 5′-GCAGATG-
CAAAAGTCCAGGT and PAX6RRT 5′-TTCCCAAGCAAAGATGGAAG;
Pou2f1/Oct-1 (POU2F1 5′-GCTCTTGCTTCTAGTGGCTCT and POU2R1 5′-
TGAAACTCTTCTCTAAGGCC); Pou2f2/Oct-2 (OCT2F 5′-CAAGCCTAC-
CCAGCCCAAAC and OCT2R 5′-GAAGCGGACA TTCGTCTCGA); and
Pou5f1/Oct-3 (POU5FF 5′-GAGTCCCAGGACATGAAAGC and POU5FR 5′-
AGATGGTGGTCTGGCTGAAC) were utilized for RT-PCR on RNA from lens
epithelial cell cultures. RT-PCR was performed using Superscript™ One-Step RT-
PCR with Platinum® Taq according to the manufacturer's instructions (Invitrogen).
Mouse lens epithelial cells (17EM15, 21EM1, αTN4) and 293t cells were
grown in DMEM supplemented with 10% fetal calf serum and penicillin/
streptomycin. Cells were transfected at 70% confluence with FuGENE 6
(Roche) in 12-well plates. Sox2 (Ambrosetti et al., 1997) (100 ng, 200 ng,
400 ng) and Oct-1 (Tanaka and Herr, 1990) (200 ng, 400 ng, 800 ng) expressing
plasmids were titrated in the presence of pGL2 (Promega) or pGL109, which
contains the 109-bp minimal element of the Pax6 EE upstream of the luciferasereporter gene in pGL2. pcDNA3 (Invitrogen) was added to standardize the
concentration of DNA in each experiment. 50 ng of phRL-CMV (Promega) was
included for standardization of the transfection efficiency. Cell lysates were
assayed for firefly and renilla luciferase activity on a Veritas Microplate
Luminometer using the Dual-Luciferase Reporter System (Promega). Each
experiment was performed in triplicate and the data illustrated are the average of
at least three experiments. Fold induction is the ratio of luciferase activity
detected in experiments containing pGL109 or its derivatives versus comparable
experiments with pGL2.
DNA constructs
The plasmid pETSox2-HMG was constructed by PCR amplification of the
HMG domain from Sox2, from pCMVSox2 (Ambrosetti et al., 1997). The PCR
product was subcloned into pETBlue-1 (Novagen). Oct1-GSTwas generated by
PCR amplification of the POU domain (POUS-linker-POUHD) from pCGOct-1
(Tanaka and Herr, 1990) and subcloning into pGEX-3X (Amersham Pharmacia)
in frame with GST. Sox and POU mutant transgenic constructs were generated
by PCR mutagenesis of pLNGLKS (Zhang et al., 2002) using the Quick
Change™ Site-Directed Mutagenesis Kit (Stratagene) following the manufac-
turer's instructions.
Mouse genetics
All mouse work was performed in accordance with protocols approved by
the Harvard Animal Care and Usage Committee. Oct-1+/− mice were
maintained on a C57BL/6 background (Wang et al., 2004), while Sox2βgeo2
and Pax61-NeuSey mice were maintained on a C3H/HeN background (Ekonomou
et al., 2005). Sox2βgeo/+ mice were interbred with Oct-1+/− mice to generate
Oct-1/Sox2 compound mutants. Double heterozygous offspring from these
matings were interbred. Appropriately staged embryos and their extra-
embryonic tissues were collected, and genomic DNA from extra-embryonic
tissue was screened by PCR (Nishiguchi et al., 1998; Wang et al., 2004;
Ekonomou et al., 2005). The Pax61-NeuSey allele was identified by a PCR
fragment polymorphism producing a HincII restriction site.
Transgenic mice were generated by standard methods (Nagy et al., 2003).
Staged embryos were collected and stained for β-galactosidase activity (Nagy et
al., 2003). Extra-embryonic tissue from transgenic embryos was processed for
genomic DNA preparation (Nagy et al., 2003). DNA was genotyped by PCR
with primers specific to the LacZ gene. β-Galactosidase-positive embryos were
dehydrated, embedded in wax, and sectioned (10 μM, transverse plane) with a
microtome. Sections were counterstained briefly with hematoxylin or eosin,
mounted, and photographed on a Zeiss Axiophot microscope with a Leica
DFC300 digital camera.
Immunofluorescence and in situ hybridization
For all paraffin processing, embryos were fixed overnight in 4%
paraformaldehyde (PFA), washed in 1× PBS, dehydrated, and embedded in
wax. 8–10 μM transverse sections were cut on a microtome. For all frozen
sections, embryos were fixed for 1 h in 4% PFA, equilibrated in 30% sucrose,
and frozen in OCT (Tissue-Tek). 10 μm transverse sections were cut on a
cryostat (Leica CM1900).
Pax6 immunofluorescence was performed on frozen sections as described
(Purcell et al., 2005). Antibody staining for Sox2 (Chemicon International, 1:500),
Oct-1 (Santa Cruz, 1:200), and E-cadherin (Zymed®, 1:1000) were performed on
frozen sections. Detection of Pax6, Oct-1, and Sox2 was enhanced by boiling in
VECTOR® Antigen Unmasking Solution (for data on the specificity of the Oct-1
and E-cadherin antibodies, see Fig. S3). Indirect visualization for all immunolo-
calization was achieved using secondary antibodies with fluorescent conjugates.
These antibodies included anti-rabbit, anti-mouse, anti-rat Cy3 (Jackson
Immunologicals, 1:500) and anti-rabbit Alexa-Fluor 488 (Molecular Probes,
1:700). All fluorescent sections were mounted with Vectashield® plus DAPI
(Vector Laboratories) and visualized on a Zeiss Axiophot microscope. A Leica
DFC350F Digital Camera was used to record images.
In situ hybridization using DIG-labeled RNA probes was performed using
standard procedures (Nagy et al., 2003). Alkaline phosphatase activity was
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photographed using a Leica DFC300 Digital Camera.
Protein purification and EMSAs
The Sox2-HMG domain and Oct1-GST were purified from E. coli as
described (Van Houte et al., 1995; Klemm et al., 1994). Each recombinant
protein was greater than 90% pure on Coomassie blue stained gels. EMSAs were
performed by pre-incubating pure proteins with cold, competitor oligonucleo-
tides or antibody in 20 mMHEPES, pH 7.8; 10 mM EDTA, pH 8.0; 1 mMDTT;
2 mM MgCl2; 50 mM NaCl; 5% glycerol; and 50 ng/μL poly dG–dC. After
addition of radiolabeled probes, reactions were loaded onto a running 8% native
PAGE gel at 4°C. After resolution, gels were dried, exposed to film (Kodak
XAR), and developed using an X-OMAT film processor. Titration of Sox2-
HMG onto EE-3 began at 63 nM and increased in 1.5-fold concentration steps.
For cooperative binding studies, the initial concentration of Oct1-GST was
15 nM and increased 1.2-fold in each subsequent lane. The concentration of
Sox2-HMG was 328 nM. For IC50 ratio calculations, Sox2-HMG (328 nM) was
incubated with cold competitor and radiolabeled EE-3 at ratios ranging from
0.1× to 100×. For IC50 ratio and cooperativity calculations, gels were analyzed
using a Phosphor Imager (Molecular Dynamics) (for representative EMSAs see
Fig. S6).Fig. 1. Pax6, Sox2, and Pou2f1 are broadly co-expressed in anterior pre-placode
stage E8.5 embryos. Whole mount in situ analysis of Pax6 (A–B), Sox2 (C–D)
and Pou2f1 (E–F) in E8.5 embryos displayed in a frontal view (A, C, E), lateral
view (B, D, F), or in cross-section (E′). The white line in panel E indicates plane
of section for panel E′. Abbreviations: nf, neural folds; ov, optic vesicle; se,
surface ectoderm. Scale bars: 100 μm in all figures.Results
Sox2, Pax6, and Pou2f1 are co-expressed in developing lens
and nasal placodes
To identify potential POU family co-factors for Sox2 in the
lens, we performed RT-PCR on total RNA collected from E13.5
wild-type eyes and from several lens epithelial cell lines (Fig.
S1). This screen identified Pou2f1, which encodes the Oct-1
protein, as a candidate POU co-factor for Sox2 in the lens.
Interestingly, Pou5f1, which encodes Oct-3, a known Sox2
interacting factor (Ambrosetti et al., 1997) was not detected in
lens epithelial cells (Fig. S1).
To determine the in vivo relationship amongst Sox2, Pax6
and Pou2f1, we examined their expression at pre-placodal
stages. Pax6, Sox2, and Pou2f1 were broadly expressed in the
E8.5 embryonic head (Figs. 1A–F). Upon cross-section,
Pou2f1 expression was detected in neural ectoderm (Fig. 1E′)
and resembled that reported for both Pax6 and Sox2 at this time
(Grindley et al., 1995; Wood and Episkopou, 1999).
To definitely determine the relative onset of Pax6, Sox2 and
Oct-1 expression in the presumptive lens ectoderm (PLE), we
performed immunofluorescence on mouse embryos staged
between 12 and 17 somites (E8.5). Pax6 protein was already
observed in the PLE at the 12-somite stage and its expression
was maintained in all subsequent stages (Figs. 2A–C). Sox2, on
the other hand, was not detected at the 12-somite stage in the
PLE (Fig. 2D). Sox2 protein was first detected in the PLE at the
15-somite stage and was maintained through subsequent pre-
placodal stages (Figs. 2E–F). Similar to Sox2, Oct-1 was not
detected in the PLE at the 12-somite stage, but was expressed by
the 15-somite stage and maintained through subsequent stages
(Figs. 2G–I). Thus, Pax6 expression precedes both Sox2 and
Oct-1 in the PLE.
We next evaluated Pax6, Sox2 and Oct-1 protein expression
in the lens placode and during early lens differentiation (Figs.
3A–I). At E9.5, Sox2 and Pax6 were strongly co-expressed inthe lens placode (Figs. 3A–C), while Oct-1 protein was
expressed in the ocular and peri-ocular region including the
lens placode (Fig. 3G). Sox2 and Pax6 remained co-expressed
throughout placode invagination and lens vesicle formation
(Figs. 3D–F) until Sox2 was down-regulated at E12.5
Fig. 2. Pax6 precedes Sox2 and Oct-1 in the PLE. Immunofluorescence for Pax6
(red, A–C), Sox2 (green, D–F), and Oct-1 (red, G–I) are shown for embryos at
the 12-somite (s) (A, D, G), 15s (B, E, H), or 17s stages (C, F, I). Arrows highlight
nuclei positive for Sox2 or Oct-1 expression in the PLE.Abbreviations: OV, optic
vesicle; PLE, presumptive lens epithelium.
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expression was excluded from the peri-ocular region but
maintained in the lens vesicle (Fig. 3H). At E13.5, Oct-1
expression was down-regulated in lens fiber cell nuclei but
maintained in the anterior epithelial layer (AEL) (Fig. 3I). Thus,
Pax6, Sox2 and Oct-1 are expressed in the developing lens until
epithelial and fiber cells differentiate. Upon differentiation,
Sox2 expression is down-regulated throughout the lens, while
Oct-1 and Pax6 expression are maintained in the AEL and
down-regulated in the fiber cells of the posterior lens.
We also evaluated the expression of Sox2, Oct-1 and Pax6
proteins during nasal placode induction and early nasal
morphogenesis (Figs. 4A–L). Pax6, Sox2, and Oct-1 were
all expressed in the nasal placode at E9.0 (Figs. 4A–C).
Thereafter, all three proteins continued to be expressed in most
cells of the nasal pit (Figs. 4D–F) and in early derivatives of
the placode, including the nasal epithelium and the developing
vomero nasal organ (VNO) (Figs. 4G–L). Thus, similar to the
lens, Pax6, Oct-1 and Sox2 are co-expressed in the nasal
placode, during nasal pit formation and in early nasal placode
derivatives.
Pou2f1 and Sox2 loss-of-function alleles interact genetically in
lens development
To determine if Sox2 affects lens placode induction and
early lens morphogenesis in cooperation with either Pax6 or
Oct-1, we genetically compounded Pax6Sey/+ and Sox2βgeo2/+
mice and Oct1+/− and Sox2βgeo2/+ mice (Wang et al., 2004;
Ekonomou et al., 2005). Early embryonic lethality in Sox2
null mice precluded our assessment of lens placode induction
in the Sox2 null state (Avilion et al., 2003). Sox2+/−, Pax6Sey/+
compound embryos, from E9.5 to E13.5, had patterns of Pax6
lens expression that were indistinguishable from those in
Sox2+/− or Pax6Sey/+ lenses (Fig. S2). While lens dysmor-
phology due to reduced Pax6 gene dosage was evident in
both Pax6Sey/+ and Sox2+/−, Pax6Sey/+ lenses from E11.5,
Sox2+/−, Pax6Sey/+ lenses were no more severely affected
than Pax6Sey/+ lenses (Fig. S2). Thus, superposition of
Sox2βgeo2 heterozygosity does not exacerbate the Pax6Sey/+
lens phenotype. While Sox2 and Pax6 are co-expressed in the
PLE from the 15-somite stage through early lens morphogen-
esis, no genetic interaction between Pax61-NeuSey and Sox2-
alleles was detected.
Since Oct-1 expression coincides with that of Sox2, we
next tested whether Sox2 and Pou2f1 are important for lens
placode induction and early lens morphogenesis by inter-
crossing Oct1+/− (Wang et al., 2004) and Sox2βgeo2/+ mice
(Ekonomou et al., 2005). From E9.5 to E11.5, Oct-1+/−, Sox2+/−
embryos exhibited grossly normal lens morphology and normal
patterns of Pax6 expression (Fig. S2). However, unlike either
Sox2+/− or Oct-1+/− mice, 100% (n=9) of Oct-1+/−, Sox2+/−
double heterozygotes developed cataracts by 6 weeks of age (Fig.
S2). Thus, similar to Pax6Sey/+ mice, Oct-1+/−, Sox2+/−
compound mutant mice exhibit a discrete late defect in lens
development, whereas mice heterozygous for either mutation
alone do not.Severely affected Sox2/Oct-1 compound mutants have
anophthalmia
We next evaluated lens placode induction and early lens
development in Oct-1−/− and Oct-1−/−, Sox2+/− embryos (Figs.
5A–I) up to E12.5, since Oct-1−/− embryos begin to die at this
stage (Wang et al., 2004). At E10.5, Oct-1−/− lenses had normal
morphology but were occasionally small (Figs. 5A–B),
reflecting the reduced size of Oct-1−/− embryos (Wang et al.,
2004). In contrast, Oct-1−/−, Sox2+/− lenses exhibited a variable
phenotype that ranged from small lenses to a complete failure of
lens induction (Figs. 5C, F). The variable phenotype in
Oct-1−/−, Sox2+/− lens induction occurred in the same animal,
and therefore did not reflect different genetic backgrounds.
Mildly affected Oct-1−/−, Sox2+/− lenses resembled those of
Pax6Sey/+ (Figs. 5C–D), whereas the entire peri-ocular region
of severely affected Oct-1−/−, Sox2+/− embryos resembled
that in Pax6Sey/Sey embryos (Figs. 5E–F). At E12.5, Oct-1+/−,
Fig. 3. Sox2, Pax6 and Oct-1 are co-expressed during lens placode induction and early eye morphogenesis. Immunofluorescence and nuclear co-localization (DAPI,
blue) of Pax6 (red, A, C, D, F), Sox2 (green, B–C, E–F), and Oct-1 (red, G–I) at E9.5 (A–C, G), E11.5 (D–F, H) and E13.5 (I) in the ocular region. (For Oct-1 antibody
controls, see Fig. S3). Abbreviations: ael, anterior epithelial layer; fc, fiber cell compartment; lp, lens placode; lv, lens vesicle; nr, neural retina; ov, optic vesicle.
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lenses were small and dysmorphic or absent (Figs. 5H–I).
Reciprocal signaling between the PLE and the optic vesicle
(OV) is an integral part of early eye development and depends
upon the close physical apposition of OV to PLE. The
apposition of OV to PLE appears normal even in severely
effected Oct-1−/−, Sox2+/− eyes (Fig. 5F), thus failed physical
association between the OV with the PLE does not cause the
observed anophthalmic phenotypes.
To better understand the defects in Oct-1−/−, Sox2+/− lenses,
we evaluated the expression of the lens and surface ectoderm
markers Pax6, E-cadherin and Sox2 (Figs. 6A–O). At E10.5,
Oct-1−/− lenses had normal patterns of Pax6, E-cadherin, and
Sox2 expression (Figs. 6A–C, see also Fig. S3). In contrast,
Oct-1−/−, Sox2+/− embryos exhibited disrupted marker expres-
sion (Figs. 6G–L). In mildly affected eyes, a small domain-
positive for all three markers was observed separate from the
surface ectoderm, indicating the presence of a small lens
primordium (Figs. 6G–I, circles). In severely affected eyes,
Pax6 and Sox2 expressions were both absent from the surfaceectoderm, while E-cadherin was maintained (Figs. 6J–L). These
data indicate that, while the surface ectoderm was intact, lens
placode induction failed.
The ocular regions of severely affected Oct-1−/−, Sox2+/−
embryos, including the lens and OV, closely resembled those of
Pax6Sey/Sey embryos in both morphology and marker expression
(Figs. 6J–O). Pax6 expression in the surface ectoderm was lost
in both mouse models (Figs. 6J, M), and Sox2 expression was
absent from the surface ectoderm and the distal OV (Figs. 6L,
O, arrow heads). Thus, while lens placode induction and
subsequent lens morphogenesis appear normal in Sox2+/− and
Oct1−/− embryos, Oct1−/−, Sox2+/− embryos have severe
defects in lens placode induction that closely resemble those
in Pax6Sey/Sey mutants.
Since Oct-1 and Sox2 are both expressed in the OV and the
ocular defects in Oct-1−/−, Sox2+/− embryos include altered
expression of Pax6 and Sox2 in the distal OV (see above), it is
possible that defects in lens placode induction can be
exacerbated by defects in the OV. To evaluate the integrity
of the OV we performed in situ hybridization for Six3 (Figs.
Fig. 4. Sox2, Pax6 and Oct-1 are co-expressed in the nasal placode, nasal epithelium and vomero nasal organ (VNO). Immunofluorescence and nuclear co-localization
(DAPI, blue, D–F) of Pax6 (red, A, D) (green G, J), Sox2 (green, B, E, H, K), and Oct-1 (red, C, F, I, L) at E9.0 (A–C), E10.5 (D–F) and E12.5 (G–L). Abbreviations:
ne, nasal epithelium; np, nasal placode; npt, nasal pit; p-lp, pre-lens placode; vno, vomero nasal organ.
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S5C–D), which are important for formation of the retinal
anlage and influence the neural potential of the retina,
respectively (Lagutin et al., 2001; Carl et al., 2002; Esteve et
al., 2003; Van Raay et al., 2005). Expression of both Six3 and
sFrp2 expression in the Oct-1−/−, Sox2+/− OV were main-
tained, while Six3 transcripts were absent from the surface
ectoderm (Fig. S5B). Thus, while the Oct-1−/−, Sox2+/−
mutant OV is abnormal, the expression of some genes
important for retinal development is maintained.
Nasal placode induction fails in Sox2/Oct-1 compound mouse
mutants
Additional evidence that Sox2 and Pou2f1 act synergistically
to control placode induction was obtained by evaluating
Oct-1−/−, Sox2+/− embryonic heads at E10.5. While theheads of Oct-1−/− and Sox2+/− embryos were indistinguish-
able from wild-type embryos (data not shown), the heads of
Oct-1−/−, Sox2+/− embryos were abnormal (Figs. 7A–E). In
E10.5 wild-type embryos, the ocular region and nasal pits
were clearly visible (Figs. 7A, E). In contrast, Oct-1−/−,
Sox2+/− embryos had no observable nasal pits and the
ocular region was either not evident (Fig. 7C) or shifted
towards the anterior (Figs. 7B, D–E).
Given the abnormal head and placode appearance, we
evaluated nasal placode induction and early nasal morphogen-
esis in Oct-1−/− and Oct-1−/−, Sox2+/− embryos (Figs. 7F–O).
In Oct-1−/− mice, nasal placodes were induced and Pax6 and
Sox2 expression were normal (Figs. 7F–G). Unlike Oct-1−/−
mice, however, Oct-1−/−, Sox2+/− embryos had neither
detectable nasal placodes nor detectable Pax6 expression
(Fig. 7I). Sox2 expression was also lost in Oct-1−/−, Sox2+/−
embryos (Fig. 7K). The lack of nasal placodes combined with
Fig. 5. Compound Oct1−/−, Sox2+/− mutant embryos display severe ocular defects. Histological analyses of E10.5 wild-type (A), Oct1−/− (B), Oct1−/−, Sox2+/− (C, F),
Pax6Sey/+ (D) and Pax6Sey/Sey (E) embryos. Histological analyses of E12.5 Oct+/−, Sox2+/− (G) and Oct1−/−, Sox2+/− (H–I) embryos. Asterisk (*) in panel C indicates
lens primordium (see Fig. 6) and asterisk (*) in panel I indicates a lack of lens tissue (see Fig. S4 for marker analyses). Abbreviations: ael, anterior epithelial layer; fc,
fiber cell compartment; pt, lens pit; nr, neural retina; ov, optic vesicle; se surface ectoderm.
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in Pax6Sey/Sey embryos (Figs. 7H, J). Thus, the nasal ectoderm
of Oct-1−/−, Sox2+/− embryos resembles that of Pax6Sey/Sey
embryos. Unlike the variable phenotype observed in the lens
placodes of Oct-1−/−, Sox2+/− embryos, however, nasal
placodes were never detected.
To confirm that nasal placode induction completely failed,
we assessed Oct-1−/−, Sox2+/− embryos at E12.5 for nasal
placode derivatives. Although E-cadherin was uniformly
expressed throughout the nasal epithelium and developing
VNO in Oct-1+/−, Sox2+/− and Pax6Sey/+ embryos (Figs.
7L–M), no E-cadherin expression was detected in Oct-1−/−,
Sox2+/− or Pax6Sey/Sey embryos (Figs. 7N–O). Thus, similar
to Pax6Sey/Sey embryos, the induction of the nasal placodes
fails and all nasal placode derivatives are absent in Oct-1−/−,
Sox2+/− embryos.
The Pax6 EE contains Sox2 and Oct-1-binding sites
Given the severity of the Oct-1−/−, Sox2+/− eye and nasal
phenotypes, we hypothesized that Sox2 and Oct1 act
cooperatively to control the expression of genes required for
lens and nasal placode induction. Given the similarity between
the phenotype of Oct-1−/−, Sox2+/− and Pax6Sey/Sey embryos,
an obvious candidate for such regulation is Pax6 (Hogan et
al., 1988; Hill et al., 1991; Glaser et al., 1994; Hanson et al.,1994; Grindley et al., 1995; Sisodiya et al., 2001). Two Pax6
lens enhancers, the ectoderm enhancer (EE) and the SIMO
enhancer, have been identified (Williams et al., 1998;
Kammandel et al., 1999, Kleinjan et al., 2001) (Fig. 8A).
Moreover, while Aota et al. (2003) previously identified three
Sox-binding sites in the EE (Table 1A–B, Sox sites A–C), our
analysis of the sequence in and around these Sox sites also
revealed the presence of a nearly perfect octamer element (5′-
ATTCAAAT-3′) which overlaps with Sox site C (Table 1A–B,
Octamer).
To confirm that Sox2 protein binds the EE, we purified the
HMG domain of Sox2, Sox2-HMG, and titrated it onto an EE
subfragment, EE-3, in EMSAs (Table 1B). These experiments
demonstrated that at least two Sox HMG domains could
simultaneously occupy the Sox sites in the EE, with occupation
of the second binding site producing a slower migrating dimeric
complex (Fig. 8B, lanes 1–16). Thus, Sox2 can directly bind
multiple sites in the EE.
To test the ability of the Octamer element to bind Oct-1, we
performed EMSAs with the POU domain of Oct-1 fused to
GST, Oct1-GST (Fig. 8B, lanes 17–20). The combination of
Oct1-GSTand probe EE-3 resulted in the formation of a specific
protein–DNA complex. The specificity of this protein–DNA
interaction was demonstrated with an antibody specific to Oct-1
that produced a weak super-shift complex (SS) and largely
eliminated the Oct1-GST-EE3 protein–DNA complex (Fig. 8B,
Fig. 6. Lens placode induction fails in severely affected Oct1−/−, Sox2+/− embryos. Immunofluorescence of E10.5 Oct1−/− (A–C), Pax6Sey/+ (D–F), Oct1−/−, Sox2+/−
(G–L), and Pax6Sey/Sey (M–O) embryos for Pax6 (green, A, D, G, J, M), E-cadherin (red, B, E, H, K, N), and Sox2 (green, C, F, I, L, O). DAPI nuclear stain is blue.
Circles indicate small lenses. Asterisk (*) in panels J and M indicate non-specific Pax6 antibody staining in embryos that have lost Pax6 expression. Arrowheads in
panels L and O indicate the domain devoid of Sox2 expression in the distal OV, while the arrows in panels J–L indicate the surface ectoderm. Abbreviations: pt, lens
pit; nr, neural retina; ov, optic vesicle; se, surface ectoderm.
791A.L. Donner et al. / Developmental Biology 303 (2007) 784–799lanes 18–19). In contrast, an antibody against the related POU
factor, Brn3a, had no affect on protein–DNA complex
formation (Fig. 8B, lane 20).
We also tested whether Sox2 and Oct-1 bound the EE
cooperatively. Previous reports have demonstrated both coop-
erative DNA binding between Sox2-HMG and the POU domainof Oct-3 and an interaction between Sox2-HMG and the Oct-1
POU domain in the absence of DNA (Ambrosetti et al., 1997).
EMSAs in which Oct1-GST was titrated onto EE-3 alone or in
the presence of constant amounts Sox2-HMG were performed
(Fig. 8C). The concentration of Sox2-HMG utilized was
sufficient to bind the EE-3 as a monomer in the absence of
Fig. 7. Nasal placode induction fails inOct1−/−, Sox2+/−mutant embryos. (A–D) Photographs of the heads of E10.5 wild-type (A), orOct1−/−, Sox2+/−mutant embryos (B–
D). (E) Diagram illustrating inappropriate location of a small lens placode in an Oct1−/−, Sox2+/− embryo between the normal sites of lens and nasal placode formation.
Immunofluorescence for Pax6 (red, F) and Sox2 (green, G) overlaid with DAPI (blue, F–G) in Oct1−/− E10.5 nasal pits. Immunofluorescence for E10.5 Pax6 (red, H–I),
Sox2 (green, J–K), and E-cadherin (red, J–K) inPax6Sey/Sey (H, J) andOct1−/−, Sox2+/− (I, K) embryos. DAPI nuclear stain is blue (H–J). (L–O) Epithelial derivatives of the
nasal placode are absent at E12.5. E-cadherin (red, L–O) immunofluorescence is shown with DAPI nuclear stain forOct1+/−, Sox2+/− (L), Pax6Sey/+ (M),Oct1−/−, Sox2+/−
(N), and Pax6Sey/Sey (O) embryos. Abbreviations: lp, lens placode; ne, nasal epithelium; npt, nasal pit; tg, tongue; vno, vomero nasal organ.
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increased in the presence of Sox2, an Oct-1/Sox2 complex of
extremely slow mobility became increasingly abundant (Fig.
8C, lanes 10–15). The amount of complex formation in the
presence of both Oct-1 and Sox2 exceeded the sum of the
complexes formed when Oct-1 and Sox2 were incubated with
EE-3 separately. Thus, in vitro, Oct-1 and Sox2 bind the EE in a
positively cooperative manner.
Mutations in Sox- and Octamer-binding sites disrupt complex
formation on the Pax6 EE
To test the importance of the Sox and Octamer DNA-binding
sites for the activity of the EE in vivo, we first analyzed the
ability of specific EE mutants to eliminate or weaken Sox2 and
Oct-1 binding in vitro. Since the Sox2-binding site in the EE isminimally a duplex site, DNA mutations that affect Sox2
binding had to be identified empirically. This was particularly
critical given the overlap between Sox Site C and the Octamer
element (Table 1A–B). Based on the single site in vitro
selection data of Mertin et al. (1999), a series of oligonucleo-
tides containing mutations in and around the Sox sites in EE-3
were generated (Table 1C). The simplest mutations were single
nucleotide substitutions at position 4 of Sox-binding sites A and
B (Table 1C, SOXAM4 and SOXBM4). DM4 combined these
two position 4 mutations (Table 1C), while SOXX contained
two mutations in each of the same two Sox-binding sites (Table
1C). In EE-3C, the central region where the Sox sites A and B
overlap was altered, while the mutant EE-3E obliterated the
center of Sox Site C.
Each mutant Sox site was tested in the form of an
unlabeled competitor DNA for its ability to disrupt
Fig. 8. Sox2 and Oct-1 proteins interact cooperatively with the Pax6 EE. (A) Schematic representation of Pax6 showing the two major promoters (P0, P1), the 5′
ectoderm enhancer (EE) and the 3′ SIMO lens enhancer. (B) Purified Sox2-HMG protein forms monomeric and dimeric protein–DNA complexes when titrated onto
radiolabeled EE-3 (for sequence, see Table 1B) in EMSA (lanes 1–16). Purified Oct1-GST forms a protein–DNA complex with EE-3 (Oct1). This complex is
diminished and super-shifted (SS) by an Oct-1 specific antibody (lanes 18–19) but unaffected by a Brn3a antibody (lane 20). (C) Titration of Oct1-GST onto EE-3 in
the absence (lanes 1–8) or presence of constant amounts of Sox2-HMG protein (lanes 9–15). Shifts due to Oct1-GST binding (Oct1), Sox2-HMG (Sox2) and the co-
complex (Oct1/Sox2) are indicated.
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probe in EMSAs. The molar ratio of cold mutant competitor
to radiolabeled EE-3 at which 50% of the shifted complex
was lost was defined as the IC50 ratio (Table 2: for the
representative EMSAs, see Fig. S6). The number of Sox site
nucleotide substitutions correlated directly with decreased
competitor function in EMSA (Table 2). Mutation of Sox site
C, in EE-3E, had no effect on the affinity of Sox2-HMG for
the EE-3 subfragment (Table 2). This is consistent with the
observation of Aota et al. (2003) that Sox site C did not
contribute to Sox-dependent transactivation of the EE in cell
culture. Thus, we discounted the Sox site C as a candidate
Sox2-binding site.We also tested the importance of sequences in the Octamer
element for Oct1-GST-EE protein–DNA complex formation by
mutating nucleotides necessary for Oct-1 protein–DNA inter-
action (Di Rocco et al., 2001) (Table 1C). As expected,
mutation of either the POU-specific (POUS, OCTPM) or POU-
homeodomain (POUHD, OCTHM) DNA recognition sites
dramatically reduced complex formation in competitive
EMSAs (Fig. S6).
Sox2 and Oct-1 synergistically transactivate the Pax6 EE
Consistent with the observations of Aota et al. (2003) and
Zhang et al. (2002), the introduction of the minimal 109-bp
Table 2
IC50 ratios for Sox2-HMG and EE-3 variants
Competitor IC50 ratio
EE-3 4
EE-3E 5
SOXAM4 48
SOXBM4 21
DM4 52
SOXX 41
EE-3C 56
Table 1
Sequences of EE subfragments, consensus binding sites, EMSA probes,
luciferase mutants and transgenic constructs
*Wild-type sequence is lower case, while mutated nucleotides are upper case
and bold.
1Identified herein.
2Aota et al. (2003).
Fig. 9. Oct-1 and Sox2 synergistically transactivate the Pax6 EE in epithelial
cells. Fold induction of luciferase activity in the presence of increasing
concentrations of plasmids encoding Sox2 (a: 100 ng, b: 200 ng, c: 400 ng) and
Oct-1 (a: 200 ng, b: 400 ng, c: 800 ng), in isolation or together on EE109,
SOXX, OCTX, IR, and DR luciferase reporter constructs in 293t epithelial cells.
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experiments results in transcriptional repression compared to
controls. We observed transcriptional repression in each of the
lens epithelial cell lines tested 17EM15, 21EM1, αTN4, B3, N/
N1003A, and LEP2 (data not shown). The strong repression
mediated by the Pax6 EE forced the evaluation of the Pax6- and
Sox2-binding sites out of context of the EE (Aota et al., 2003)
and the analysis of the Meis-binding site with a fusion protein
containing the exogenous transcriptional activation domain
from VP16 (Zhang et al., 2002). While both of these approaches
were useful in providing information about the regulation of the
EE, we believe they limit the value of a cell culture system in
representing in vivo interactions. Since there is no cell culture
model that accurately recapitulates lens placode induction, we
utilized a non-lens epithelial cell line, 293t, in which EE109 is
weakly repressed compared to controls (0.8-fold). This allowed
us to assess transcriptional activation in the context of the
endogenous enhancer and eliminated the need for a non-native
transcriptional activation domain.
We transfected 293t cells with increasing concentrations of
Sox2 or Oct-1 encoding plasmids, alone or in combination in
the presence of pGL109 or pGL2. Sox2 and Oct-1, in isolation,
elicited 2.6-fold and 1.4-fold activation of the pGL109,
respectively (Fig. 9, EE109). The combination of Sox2 and
Oct-1 resulted in 4.4-fold increase in luciferase activity. The
increase in activation observed is consistent with Sox2 andOct-1 having a slightly synergistic effect on Pax6 EE activity.
To ensure that the observed transcriptional activation was
dependent upon the Sox and Octamer elements identified
herein, we utilized two mutant luciferase constructs, SOXX and
OCTX (Fig 9, see also Table 1C). SOXX, derived from
pGL109, has the same sequence substitutions as the SOXX
mutation described for IC50 ratio calculations. OCTX is
similarly derived from pGL109, but contains 4-bp substitutions
(two in each half-site of the Octamer element, Table 1C).
Transcriptional activation in the presence of Sox2 and Oct-1,
individually or in combination was compromised on both of
these altered enhancers. Indeed, Sox2-dependent activation of
the EE was largely abolished by mutation of either the Sox
sequence (maximum activation 1.5-fold) or the Octamer
element (maximum activation 1.5-fold) (Fig. 9, OCTX),
indicating that Sox2-dependent activation, in the absence of
any exogenous Oct-1, is dependent upon the presence of an
Table 3
β-Galactosidase expression in transgenic embryos
Transgene No. expressing in:
Stage Lens Cornea Ectoderm No. Tg
EE526 E10.0 5 NA NA 5
E12.5 10 10 10 14
SOXAM4 E12.5 1 1 1 12
SOXBM4 E12.5 4 0 0 10
DM4 E10.0 0 NA NA 2
E12.5 2 a 1 0 8
SOXX E10.0 0 NA NA 4
E12.5 0 0 0 23
OCTHM E10.0 0 NA NA 9
E12.5 9 0 0 12
OCTPM E12.5 1 0 0 3
MPAX6 E12.5 0 0 0 7
NA, not applicable.
a Patchy, weak expression.
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POU factor. The sum of Sox2-dependent activation and Oct-1-
dependent activation was statistically significantly lower than
the Sox2/Oct-1-dependent activation of the EE (p<0.005, t-
test). Thus, Sox2/Oct-1 activation of the Pax6EE through the
Sox and Octamer sites is synergistic.
To determine the relative contribution of the two Sox sites (A
and B) to the Oct-1/Sox2-dependent activation of the EE, we
utilized two constructs, IR and DR (Fig. 9, IR and DR, see also
Table 1C). IR contains mutations in Sox site A: the Octamer
element and the Sox site B are intact. DR contains mutations in
Sox site B such that the Octamer element and Sox site A are
intact. Transcriptional activation was not observed on the IR
construct (Fig. 9, IR). Sox2-dependent and Sox2/Oct-1 co-
activation, however, were observed on the DR template (Fig 9,
DR). These results indicate that Sox2 and Oct-1 synergistically
activate the Pax6 EE by interaction with the Octamer element
and Sox site A.
Mutations in Sox and Octamer DNA sites reduce the activity of
the Pax6 EE in vivo
Since cell lines do not accurately recapitulate the environ-
ment of the developing lens placode or early differentiating
lenses, we assessed the consequences of mutating the Sox-
binding sites on Pax6 EE activity in transgenic mouse embryos.
The wild-type transgene used in these studies contained 526 bp
of the Pax6 P0 upstream region, including the EE, and yieldedFig. 10. Sox and Octamer DNA-binding elements are required for the in vivo trans
constructs utilized. The Pax6 EE directs expression of LacZ through the TATA elemen
embryo at E10.0 and representative sections of E12.5 embryos transgenic for EE52
E10.0, the non-lens epithelium of EE526, SOXAM4 and SOXBM4 sections and thehighly efficient transgene expression that recapitulated the
endogenous Pax6 expression pattern in 5 out of 5 and 10 of 14,
E10.0 and E12.5 embryos, respectively (Figs. 10A–B; Table 3).
In contrast, the singly mutant transgenes, SOXAM4 and
SOXBM4, each exhibited a reduced efficiency of transgene
expression at E12.5 (1 of 12 and 4 of 10, respectively), while
SOXBM4 also exhibited an altered pattern of expression
(Table 3). Specifically, activity of the EE in the presumptive
cornea and glandular ectoderm was abolished in SOXBM4
transgenic embryos (Fig. 10B). Mutation of both Sox sites in thecriptional activity of the Pax6 EE. (A) Schematic representation of transgenic
t of the human β-globin (βg) gene. (B) Whole mount photo of EE526 transgenic
6, SOXAM4, SOXBM4, OCTPM, and OCTHM. The arrows indicate the lens at
AEL of OCTPM and OCTHM images.
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both E10.0 and E12.5 (Table 3); the two transgenic embryos
that expressed β-galactosidase at E12.5 exhibited patchy, weak
expression that was not detectable in serial cross-sections (data
not shown). The transgene SOXX, with the most severe
mutations in the duplex Sox sites by in vitro criteria, had no
detectable in vivo activity (Table 3). Thus, the effects of the
various mutations on Sox binding in vitro correlate directly with
their effects on EE expression in vivo. Furthermore, the duplex
Sox sites A and B are necessary for EE activity in the lens pit,
the differentiating lens, the presumptive cornea and ocular
glandular ectoderm.
We also assayed the in vivo activity of the EE with a mutated
Octamer element. At E10.0, mutation of the POUHD half-site
abolished enhancer activity in the lens (Table 3, OCTHM). At
E12.5, transgenic embryos with mutations in either the POUS or
POUHD half-site behaved similarly, with the absence of all
ectoderm expression outside the lens (Fig. 10B; Table 3).
Interestingly, the effect of these mutations in the differentiating
lens was not uniform. Expression in the AEL was maintained in
OCTPM and OCTHM transgenic embryos, while expression in
the fiber cell compartment was lost (Fig. 10B). The Octamer
element is therefore necessary for Pax6 EE activity in the lens
pit, the lens primary fiber cells and in the ectoderm surrounding
the lens at E12.5. It is not, however, necessary for the activity of
the Pax6 EE in the AEL. In total, our in vivo transgenic data
demonstrate that the Octamer and Sox DNA-binding sites are
each required for activity of the Pax6 EE in the early lens, the
differentiating lens and the peri-ocular ectoderm and that the
utilization of these sites is distinct in the differentiating lens
epithelium and primary fiber cells.
Discussion
Sox2 and Oct-1 are co-factors required for lens and nasal
placode induction
While Sox transcription factors can bind similar DNA
sequences (Kamachi et al., 1999), individual Sox proteins
control distinct downstream targets (Kamachi et al., 1999,
2000). Thus, it is believed that Sox factors affect transcription
by forming complexes with other proteins, and that accessory
co-factors provide transcriptional specificity. Pax6 and Oct-3
are two co-factors that have been characterized for Sox2
(Ambrosetti et al., 1997; Kamachi et al., 2001; Aota et al., 2003;
Rodda et al., 2005; Okumura-Nakanishi et al., 2005). Here, we
identify Oct-1 as an important co-factor for Sox2 during lens
and nasal placode induction.
In contrast to previous reports that Oct-1 is ubiquitously
expressed (reviewed in Ryan and Rosenfeld, 1997), we find that
during embryonic development Oct-1 exhibits a developmen-
tally dynamic and tissue-specific pattern of expression. The
dynamic profile of Oct-1 expression overlaps extensively with
that of Sox2 in the early neuroepithelium, in the lens and nasal
placodes and their derivatives. While heterozygous mutation of
either Pou2f1 or Sox2 alone has no phenotypic consequences
for lens or nasal development, compound heterozygousmutation of Pou2f1 and Sox2 produces ocular cataracts.
Cataracts are a sensitive readout of subtle disturbances in lens
development, and are a cardinal feature observed in Pax6Sey/+
mice.
Homozygous mutation of Pou2f1 results in small embryos
∼4% of the time (Wang et al., 2004), and consistent with this,
we observe a morphologically normal but small lens pits in a
small fraction of Oct-1−/− embryos. However, in Oct-1−/−,
Sox2+/− embryos, while lens phenotypes within a single embryo
were variable (potentially due to the hypomorphic nature of the
Oct-1 allele and see below) (Wang et al., 2004), severe defects
occurred in both lens and nasal placode induction. These
embryos generally exhibit microphthalmia in one eye and
anophthalmia in the other, and a complete failure of nasal
placode induction. Since compound mutations of Sox2 and
Pou2f1 in Oct-1+/−, Sox2+/− or in Oct-1−/−, Sox2+/− embryos
produce phenotypes not observed when the genes are mutated
independently, Pou2f1 and Sox2 act cooperatively during the
induction of the lens and nasal placodes.
Although we provide evidence for Oct-1/Sox2-dependent
activation of the Pax6 EE, it is likely that another POU factor in
the lens also interacts with Sox2 to activate Pax6 expression
through the EE. The activity of the Pax6 EE is strictly
dependent upon an intact Octamer element, but is not strictly
dependent upon Oct-1, since Pax6 expression and lens
morphogenesis are normal in Oct-1−/− embryos. Alternatively,
Oct-1 expression from the hypomorphic Pou2f1 allele, even in
the homozygous condition, may be sufficient for activation of
the EE and maintenance of Pax6 expression. Homozygous
mutation of Pou2f1 in conjunction with heterozygosity for
Sox2, however, prevents Oct/Sox2 complex formation on the
EE and disrupts expression of Pax6.
In addition to lens and nasal placode defects in Oct1−/−,
Sox2+/− mice, we have observed dysmorphology of Rathke's
pouch and the adenohypophysis (ALD and RLM, unpublished
data). Thus, all Pax6-dependent PPR derivatives are disrupted
in these embryos. These observations are consistent with the
utilization of a common molecular pathway, involving Pou2f1,
Sox2 and Pax6 in mammalian lens, nasal and Rathke's pouch
placode induction and differentiation.
Sox2 and Oct-1 maintain Pax6 expression through the EE
Sox2 and Oct-1 are important for lens and nasal placode
induction because they directly control the expression of Pax6.
Sox2 and Oct-1 proteins are first detectable in the mouse PLE at
the 15-somite stage, after the onset of Pax6 expression. Thus,
Sox2 and Oct-1 cannot be required for the initial activation of
Pax6. However, Sox2 and Oct-1 are both expressed prior to
mouse lens specification, which occurs at the 23-somite stage
(Furuta and Hogan, 1998). Furthermore, Pax6 expression is
dynamically restricted from a broad domain of the head surface
ectoderm to the PLE during pre-specification stages (Grindley
et al., 1995). Thus, Sox2 and Oct-1 may stabilize Pax6
expression in the PLE during lens specification.
Sox2 and Oct-1 bind cooperatively to the Pax6 EE and the
disruption of Sox or Octamer DNA-binding sites abolishes
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Octamer and Sox site mutations also eliminate Pax6 EE-
dependent expression in the lens of transgenic mouse embryos.
Thus, the Octamer and Sox sites identified herein are required
for the in vivo activity of the Pax6 EE.
The Pax6 EE, however, is not the only enhancer required for
appropriate Pax6 expression in the early lens (Dimanlig et al.,
2001). Indeed Pax6 expression in the head surface ectoderm,
which initiates at E8.0 (Grindley et al., 1995), precedes the
earliest detectable activity of the Pax6 EE at E8.75 (Dimanlig et
al., 2001). Thus, the Octamer and Sox elements described
herein may be necessary for the activity of the Pax6 EE without
controlling the pre-15-somite stage head surface ectoderm
expression of Pax6.
Homozygous deletion of the Pax6 EE in Pax6ΔEE/ΔEE
mice reduces Pax6 expression, delays lens placode induction
and results in microphthalmia (Dimanlig et al., 2001). Mildly
effected Oct-1−/−, Sox2+/− lenses resemble Pax6ΔEE/ΔEE
lenses, while severely effected Oct-1−/−, Sox2+/− lenses are
more severely affected than Pax6ΔEE/ΔEE lenses. There are
several possible explanations for this result. As mentioned
previously, there are at least two enhancers that control Pax6
expression in the lens. The SIMO enhancer has been shown
to direct expression to the lens placode and its derivatives in
transgenic mice (Kleinjan et al., 2001). In the most highly
conserved domain of the SIMO element there are at least
eight sites that bind Sox proteins in vitro and one Octamer
element (ALD and RLM, unpublished data). Thus, it is
possible that Oct1 and Sox2 control Pax6 lens expression
through other Pax6 enhancers such as the SIMO enhancer.
Secondly, loss of Oct-1 and Sox2 in the lens may reduce or
eliminate the expression of genes other than Pax6 that are
important for lens placode induction and subsequent differ-
entiation. Finally, the loss of Oct-1 and Sox2 in the OV may
result in non-tissue autonomous defects in lens development.
While we have assessed expression of several OV markers,
tissue-specific deletion of Pou2f1 and Sox2 will be required
to fully address this possibility since many of the molecules
required for OV-PLE signaling are not known. However,
given the existence of multiple placode defects in the Oct-1−/−,
Sox2+/− embryos and the normal physical apposition between
the OV with PLE, it is unlikely that a defect in the OV is the
exclusive cause of the observed lens placode defect.
Sox2 and Pax6 are interdependent factors required for eye
development
Sox2 and Pax6 proteins act together to regulate the
transcription of the chicken δ-crystallin gene and the Pax6
EE (Kamachi et al., 2001; Aota et al., 2003). In Sox2βgeo2/+,
Pax6Sey/+ double heterozygous mice, however, we did not
detect synergistic effects of Sox2 and Pax6 on lens placode
induction or lens differentiation. This may indicate that Sox2/
Pax6 complex formation is not essential for murine lens
placode induction or the early activity of the Pax6 EE.
Alternatively, the lack of phenotypic evidence for this
interaction may derive from the alleles utilized in this study.Embryos homozygous for the Sox2βgeo2 allele alone cannot be
evaluated for lens defects due to the severity of the early
phenotype (Avilion et al., 2003; Ekonomou et al., 2005).
Embryos homozygous for the Pax61-NeuSey allele already fail
to induce a lens placode; thus the phenotypic consequence of
Pax6Sey/Sey compounded with Sox2 mutation on lens develop-
ment cannot be meaningfully evaluated. Furthermore, mice
heterozygous for the Pax61-NeuSey allele have cataracts. Thus,
the Pax6 heterozygous mutation in isolation has the same
phenotype as Oct1+/−, Sox2+/− mice, and compounding
heterozygosity for the alleles Pax61-NeuSey and Sox2βgeo2 has
no additional phenotypic consequences.
It is notable that the Oct-1/Sox2 complex that we
identify herein and the Pax6/Sox2 complex characterized in
Aota et al. (2003) both predominately utilize Sox Site A.
Thus, alternative Sox2 complexes may control different
aspects of Pax6 regulation. For example, during lens
differentiation the Sox sites are required for Pax6 EE
activity in the AEL and the fiber cell compartment, while
the Octamer site is only necessary in the fiber cell
compartment. Thus, the Pax6/Sox complex might function
in the AEL, while the Oct-1/Sox2 complex is utilized
during primary fiber cell differentiation.
Sox2 is activated downstream of Pax6, since Sox2 expression
is lost in homozygous Pax6 null embryos (Furuta and Hogan,
1998; Ashery-Padan and Gruss, 2001). Indeed, we observe the
loss of Sox2 expression in our compound Oct-1−/−, Sox2+/−
mice in both the surface ectoderm and the distal OV. Since Sox2
expression is detectable in both Oct-1−/− and Sox2+/− mice, we
presume that this is a consequence of disrupted Pax6 expression
in the compound mutants.
Sox2 also acts upstream of Pax6 during lens induction. Our
current analyses provide evidence that Sox2, acting through the
EE, is required for the maintenance of Pax6 expression in the
mouse PLE for lens placode induction and subsequent lens
morphogenesis. Kamachi et al. (2001) demonstrated that
ectopic expression of Sox2 up-regulated Pax6 in chick head
ectoderm. Based on these data, Kondoh and colleagues
proposed that Pax6 maintenance in the chick lens is Sox2-
dependent (Kondoh et al., 2004). Our data are consistent with
the model of Kondoh et al. (2004) and expand it to include the
co-factor, Oct-1, which acts in concert with Sox2 to maintain
Pax6 expression.
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